Delivery Order SPE2D020D0005-SPE2D325F332V
Award Date 8/20/25
Potential Completion Date 8/25/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Chartwell RX LLC on August 20, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in quantities of 30 tablets. This firm fixed-price delivery order, valued at $1,184.50, represents a continuation of pharmaceutical supply support to federal military and veteran healthcare services. The contract carries no set-aside designation and is set for completion by August 25, 2025, with fulfillment...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,184.50 to Chartwell RX LLC for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. The award was issued on July 30, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. Chartwell RX LLC, a pharmaceutical company headquartered in Congers, New York, will fulfill this order from its place of performance at the same...
- The U.S. Department of Defense Medical Supply Chain has awarded a delivery order valued at $1,578.48 to Chartwell RX LLC for the supply of Ondansetron ODT (orally disintegrating tablets) 8 mg in a quantity of 30 tablets. The contract was awarded on August 11, 2025, with an ultimate completion date of August 14, 2025, and carries a firm fixed price with no small business set-aside designation. Performance will be executed at Chartwell RX's facility located in Congers, New York. Chartwell RX...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Chartwell RX LLC on August 4, 2025, for the supply of Ondansetron orally disintegrating tablets in 4 milligram strength, with a ceiling value of $1,066.05 and an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a continuation of the government's pharmaceutical supply chain through an Indefinite Delivery Vehicle contract...
- This is a delivery order awarded to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,724.35 firm-fixed-price contract is for the delivery of ondansetron orally disintegrating tablets (ODT) 4 mg, with a completion date of July 25, 2024. Chartwell RX LLC is a for-profit organization registered in the System for Award Management (SAM) that specializes in providing a wide range of branded and generic...
- This is a $1,776.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets in 30-count packages. This delivery order is issued under Chartwell RX's existing Indefinite Delivery Contract (SPE2D020D0005) with DLA, which enables the company to manufacture and distribute a broad range of...
- The Defense Logistics Agency Troop Support Medical awarded a $1,895.20 firm fixed price delivery order to Chartwell RX LLC, a for-profit organization, to provide 4,563,150,434 units of Ondansetron Orally Disintegrating Tablets (ODT) 4 mg. The delivery order has a completion date of December 26, 2023 and was awarded on December 20, 2023. Chartwell RX LLC is an established pharmaceutical supplier to the federal government, holding contracts with the Department of Veterans Affairs and the Defense...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,842.80 firm fixed-price delivery order contract to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, which runs through August 2024, is for the provision of 4565467121 ondansetron orally disintegrating tablets (ODT) 4 mg. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) with Chartwell RX, valued at over $7 million and running through March 2030,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts, including...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order to Chartwell RX LLC, a for-profit organization, to provide 30-count packages of the pharmaceutical product Ondansetron ODT 8 mg Tablet. The contract has a Potential Value of $4,932.75 and a Completion Date of January 10, 2024. The order was issued without the use of any set-aside designations. Chartwell RX LLC is an existing vendor for the Defense Logistics Agency Troop Support Medical, having previously...